Women’s Health diagnostic testing comprises of various testing and diagnostic procedures for ruling out fatal diseases such as breast cancer, cervical cancer, ovarian cancer, HPV, urinary tract infections and osteoporosis. Whereas some of the diagnostic procedures are used in prenatal screening and for evaluating pregnancy and fertility. These diagnostic tests also helps in diagnosing STDs (Sexually Transmitted Diseases) and infections. Women’s health diagnostic testing procedures are available in hospitals, clinics mainly obstetrics and gynaecology clinics, pathology laboratories and radiology centres. Also increasing number of companies are providing point of care testing devices and testing kits for home usage.
Women’s Health diagnostic testing Market: Drivers and Restraints
Women’s health diagnostic testing market is growing, this is attributed to increasing prevalence of osteoarthritis, ovarian cancer, breast cancer and cervical cancer. Also the market is expected to expand with the fastest CAGR due to increasing number of prenatal screening tests and anti-natal ultrasound along with increasing product launch for point of care testing devices. Increasing sales test kits for home usage is also expected to drive the revenue growth of women’s health diagnostic testing market over the forecast period. In addition to this, growing healthcare expenditure, and rising awareness and apprehension regarding various types of malignant tumors, infectious diseases, STDs also aids the growth of women’s health diagnostic testing market as increasing number of patients are opting for the diagnostic tests to rule the underlying cause of their symptoms. Also, availability of newer and advanced diagnostic systems along with increasing strategic partnerships among the diagnostic device manufacturing companies also drives the women’s health diagnostic testing market, giving enormous opportunities to the companies within this market. However cost of diagnostic testing procedures might hamper the revenue growth of women’s health diagnostic testing market over the forecast period
Request For Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3204
The Women’s Health diagnostic testing market is segment based on the application type and end user
Women’s health diagnostic testing market is segmented into following types:
By Application Type
- Cancer Screening
- Breast Cancer
- Ovarian Cancer
- Cervical Cancer
- Pregnancy test
- Prenatal test
- STD test
- Gynecological test
By End User
- Gynecology & Obstetrics Clinics
- Orthopedic Clinics
- Diagnostic Laboratories
- Cancer diagnostic centers
- Pathology Laboratories
- Radiology Centers
- Cancer Institutes
Women’s Health diagnostic testingMarket: Overview
Women’s health diagnostic testing market is expected to grow at a significant rate, over the forecast period. The market is anticipated to perform well over the forecast period due to increasing number of patients suffering from osteoporosis. Also increasing prevalence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques leads to more women opting for diagnostic procedures. Women’s health diagnostic testing market is expanding globally due to increasing distribution partnerships among diagnostic testing device manufactures. The women’s health diagnostic testing market is expected to grow with a fastest CAGR over the forecast period due to increasing number of people opting for endovenous laser ablation procedure for cosmetic purpose. Increasing competition among major companies in the market to develop advanced systems which provides increased precision and accuracy during treatment drives the Women’s Health diagnostic testing market towards the growth curve.
Women’s Health diagnostic testing Market: Region-wise Outlook
Depending on geographic region, the women’s health diagnostic testing market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.
North America is the largest regional market owing to high patient awareness levels regarding various diagnostic testing procedures for women, increasing healthcare expenditure, reimbursement options and relatively larger number of R&D exercises pertaining new product launch and marketing etc. these factors contribute for significant revenue generation for diagnostic testing devices from the region.
Asia Pacific is expected to grow at the fastest CAGR because of increasing prevalence of breast cancer in women. Also increase in geriatric population leads to more number of cases with osteoporosis is expected to boost the revenue growth of women’s health diagnostic testing market throughout the forecast period.
Women’s Health diagnostic testing Market: Key Players
Some players of women’s health diagnostic testing market includes GE Healthcare, Becton, Dickinson and Company, Koninklijke Philips N.V., PerkinElmer Inc., Abbott Laboratories, Quest Diagnostics Inc., Hologic, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche AG whereas some regional players also have a significant presence in Women’s Health diagnostic testing market.